https://doi.org/10.1186/s40164-023-00419-w
F
Fengying Wu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
170
Papers
4.2K
Citations
29
h-index
64
i10-index
Fengying Wu is an academic researcher from Tongji University. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Lung Cancer Research Studies. The author has an h-index of 29, co-authored 145 publications.
ORCID: 0000-0001-5129-0528Papers by this author
worksFibronectin promotes tumor angiogenesis and progression of non-small-cell lung cancer by elevating WISP3 expression via FAK/MAPK/ HIF-1α axis and activating wnt signaling pathway
2023 · Experimental Hematology and Oncology · 81 citations
Novel antibodies against GPIbα inhibit pulmonary metastasis by affecting vWF-GPIbα interaction
2018 · Journal of Hematology & Oncology · 48 citations
https://doi.org/10.1186/s13045-018-0659-4
Immune checkpoint inhibitors plus chemotherapy in patients with locally advanced or metastatic pulmonary sarcomatoid carcinoma: a multicentric real-world study
2022 · Therapeutic Advances in Medical Oncology · 14 citations
https://doi.org/10.1177/17588359221136759
Multi-omics with dynamic network biomarker algorithm prefigures organ-specific metastasis of lung adenocarcinoma
2024 · Nature Communications · 11 citations
https://doi.org/10.1038/s41467-024-53849-3
IFITM3 enhances immunosensitivity via MHC-I regulation and is associated with the efficacy of anti-PD-1/-L1 therapy in SCLC
2025 · Molecular Cancer · 5 citations
https://doi.org/10.1186/s12943-025-02383-x
Advances in modeling boundary layer turbulence and its effects on motion independent aerodynamic force of bridge decks
2022 · Advances in Bridge Engineering · 3 citations
https://doi.org/10.1186/s43251-022-00072-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat